Genetic heterogeneity within ulcerative colitis determined by an interleukin-1 receptor antagonist gene polymorphism and antineutrophil cytoplasmic antibodies

European Journal of Gastroenterology and Hepatology

Volumn 11, Issue 4, 1999, Pages 413-420

  Papo, Michel ^a   Quer, Juan Carlos ^a   Gutierrez, Cristina ^a   Broch, Montserrat ^a   Casellas, Francesc ^b   Pastor, Rosa María ^a   Olona, Montserrat ^a   Richart, Cristobal ^a  

^a HOSPITAL UNIVERSITARI JOAN XXIII   (Spain)

^b HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

Author keywords

Anti neutrophil cytoplasmic antibodies; Cytokine gene polymorphisms; Inflammatory bowel disease; Ulcerative colitis

Indexed keywords

INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; LYMPHOTOXIN; NEUTROPHIL CYTOPLASMIC ANTIBODY; TUMOR NECROSIS FACTOR ALPHA;

ADOLESCENT; ADULT; AGED; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; GENE FREQUENCY; GENETIC HETEROGENEITY; GENETIC MARKER; GENETIC PREDISPOSITION; GENOTYPE; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; INTRON; MAJOR CLINICAL STUDY; MALE; NEUTROPHIL; POLYMERASE CHAIN REACTION; POPULATION GENETICS; PRIORITY JOURNAL; PROMOTER REGION; REVIEW; SPAIN; STATISTICAL ANALYSIS; ULCERATIVE COLITIS; VARIABLE NUMBER OF TANDEM REPEAT;

EID: 0032921221     PISSN: 0954691X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042737-199904000-00010     Document Type: Review

References (53)

1. Shanahan F. Pathogenesis of ulcerative colitis. Lancet 1993; 342:407-411.
2. Yang H, Rotter JI. The genetics of inflammatory bowel disease. In: Inflammatory Bowel Disease: From Bench to Bedside. Targan S, Shanahan F (editors). Baltimore: Williams & Wilkins; 1993. pp. 32-64.
3. Hugot JP, Laurent-Puig P, Gower-Rousseau C, Olson JM, Lee JC, Beaugerie L, et al. Mapping of a susceptibility locus for Crohn's disease on chromosome 16. Nature 1996; 379:821-823.
4. Satsangi J, Parkes M, Louis E, Hashimoto L, Kato N, Welsh K, et al. Two stage genome-wide search in inflammatory bowel disease provides evidence for susceptibility loci on chromosomes 3, 7 and 12. Nature Genet 1996; 14:199-202.
5. Ohmen JD, Yang HY, Yamamoto KK, Zhao HY, Ma Y, Bentley LG, et al. Susceptibility locus for inflammatory bowel disease on chromosome 16 has a role in Crohn's disease, but not in ulcerative colitis. Hum Mol Genet 1996; 5:1679-1683.
6. Satsangi J, Jewell DP, Rosenberg WMC, Bell JI. Genetics of inflammatory bowel disease. Gut 1994; 35:696-700.
7. Satsangi J, Jewell DP, Bell JI. The genetics of inflammatory bowel disease. Gut 1997; 40:572-574.
8. Toyoda H, Wang SJ, Yang HY, Redford A, Magalong D, Tyan D, et al. Distinct associations of HLA class II genes with inflammatory bowel disease. Gastroenterology 1993; 104:741-748.
9. Duerr RH, Neigut DA. Molecularly defined HLA-DR2 alleles in ulcerative colitis and an antineutrophil cytoplasmic antibody-positive subgroup. Gastroenterology 1995; 108:423-427.
10. Satsangi J, Welsh KI, Bunce M, Julier C, Farrant JM, Bell JI, et al. Contribution of genes of the major histocompatibility complex to susceptibility and disease phenotype in inflammatory bowel disease. Lancet 1996; 347:1212-1217.
11. Masuda H, Nakamura Y, Tanaka T, Hayakawa S. Distinct relationship between HLA-DR genes and intractability of ulcerative colitis. Am J Gastroenterol 1994; 89:1957-1962.
12. Koutroubakis I, Crusius JBA, Peña AS. Immunogenetics of cytokines. Scand J Gastroenterol 1995; 30:1139-1146.
13. Cominelli F, Pizarro TT. Interloukin-1 and interleukin-1 receptor antagonist in inflammatory bowel disease. Aliment Pharmacol Ther 1996; 10(suppl 2):49-53.
14. Tarlow JK, Blakemore AIF, Lennard A, Solari R, Hughes HN, Steinkasserer A, et al. Polymorphism in human IL-1 receptor antagonist gene intron 2 is caused by variable numbers of an 86-bp tandem repeat. Hum Genet 1993; 91:403-404.
15. Mansfield JC, Holden H, Tarlow JK, Di Giovine FS, McDowell TL, Wilson AG, et al. Novel genetic association between ulcerative colitis and the anti-inflammatory cytokine interleukin-1 receptor antagonist. Gastroenterology 1994; 106:637-642.
16. Duerr RH, Tran T. Association between ulcerative colitis and a polymorphism in intron 2 of the interleukin-1 receptor antagonist gene [Abstract]. Gastroenterology 1995; 108;A812.
17. Tountas NA, Kam L, di Giovine FS, Casini-Raggi V, Cominelli F. Genetic association between allele 2 of IL-1 receptor antagonist (IL-1 ra) and ulcerative colitis in a Los Angeles based Hispanic population [Abstract]. Gastroenterology 1995; 108:A930.
18. Andus T, Caesar I, Vogl D, Schölmerich J, Gross V. Association of HLA-DR15, p-ANCA and IL-1 receptor antagonist allele 2 with ulcerative colitis [Abstract]. Gastroenterology 1995; 108:A770.
19. Bioque G, Bouma G, Crusius JBA, Koutroubakis I, Kostense PJ, Meuwissen SGM, et al. Evidence for genetic heterogeneity in IBD: the interleukin-1 receptor antagonist in the prodisposition to suffer from ulcerative colitis. Eur J Gastroenterol Hepatol 1996; 8:105-110.
20. Louis E, Satsangi J, Roussomoustakaki M, Parkes M, Fanning G, Welsh K, et al. Cytokine gene polymorphisms in inflammatory bowel disease. Gut 1996; 39:705-710.
21. Roussomoustakaki M, Satsangi J, Welsh K, Louis E, Fanning G, Targan S, et al. Genetic markers may predict disease behavior in patients with ulcerative colitis. Gastroenterology 1997; 112:1845-1853.
22. Hacker UT, Gomolka M, Keller E, Eigler A, Folwaczny C, Fricke H, et al. Lack of association between an interleukin-1 receptor antagonist gene polymorphism and ulcerative colitis. Gut 1997; 40:623-627.
23. Heresbach D, Alizadeh M, Dabadie A, Le Berre N, Colombel JF, Yaouanq J, et al. Significance of interleukin-1β and interleukin-1 receptor antagonist genetic polymorphism in inflammatory bowel diseases. Am J Gastroenterol 1997; 92:1164-1169.
24. Wilson AG, Symons JA, McDowell TL, McDevitt HO, Duff GW. Effects of a polymorphism in the human tumor necrosis factor a promoter on transcriptional activation. Proc Natl Acad Sci USA 1997; 94:3195-3199.
25. Kroeger KM, Carville KS, Abraham LJ. The -308 tumor necrosis factor-α promoter polymorphism effects transcription. Mol Immunol 1997; 34:391-399.
26. Bouma G, Crusius JBA, Oudkerk Pool M, Kolkman JJ, von Blomberg BME, Kostense PJ, et al. Secretion of tumor necrosis factor α and lymphotoxin α in relation to polymorphisms in the TNF genes and HLA-DR alleles. Relevance for inflammatory bowel disease. Scand J Immunol 1996; 43:456-463.
27. Wilson AG, di Giovine FS, Duff GW. Genetics of tumor necrosis factor-α in autoimmune, infectious, and neoplastic diseases. J Inflam 1995; 45:1-12.
28. Messer G, Spengler U, Jung MC, Honold G, Blömer K, Pape GR, et al. Polymorphic structure of the tumor necrosis factor (TNF) locus: an NcoI polymorphism in the first intron of the human TNF-β gene correlates with a variant amino acid in position 26 and a reduced level of TNF-β production. J Exp Med 1991; 173:209-219.
29. Pociot F, Briant L, Jongeneel CV, Mölvig J, Worsaae H, Abbal M, et al. Association of tumor necrosis factor (TNF) and class II major histocompatibility complex alleles with the secretion of TNF-α and TNF-β by human mononuclear cells: a possible link to insulin-dependent diabetes mellitus. Eur J Immunol 1993; 23:224-231.
30. Duerr RH, Targan SR, Landers CJ, Sutherland LR, Shanahan F. Antineutrophil cytoplasmic antibodies in ulcerative colitis: comparison with other colitides/diarrheal illnesses. Gastroenterology 1991; 100:1590-1596.
31. Sandborn WJ, Landers CJ, Tremaine WJ, Targan SR. Antineutrophil cytoplasmic antibody correlates with chronic pouchitis after ileal pouch-anal anastomosis. Am J Gastroenterol 1995; 90:740-747.
32. Sandborn WJ, Landers CJ, Tremaine WJ, Targan SR. Association of antineutrophil cytoplasmic antibodies with resistance to treatment of left-sided ulcerative colitis: results of a pilot study. Mayo Clin Proc 1996; 71:431-436.
33. Vecchi M, Bianchi MB, Sinico RA, Radice A, Meucci G, Torgano G, et al. Antibodies to neutrophil cytoplasm in Italian patients with ulcerative colitis: sensitivity, specificity and recognition of putative antigens. Digestion 1994; 55:34-39.
34. Vasiliauskas EA, Plevy SE, Landers CJ, Binder SW, Ferguson DM, Yang H, et al. Perinuclear antineutrophil cytoplasmic antibodies in patients with Crohn's disease define a clinical subgroup. Gastroenterology 1996; 110:1810-1819.
35. Shanahan F, Duerr RH, Rotter JI, Yang H, Sutherland LR, McElree C, et al. Neutrophil autoantibodies in ulcerative colitis: familial aggregation and genetic heterogeneity. Gastroenterology 1992; 103:456-461.
36. Seibold F, Slametschka D, Gregor M, Weber P. Neutrophil autoantibodies: a genetic marker in primary sclerosing cholangitis and ulcerative colitis. Gastroenterology 1994; 107:532-536.
37. Yang H, Rotter JI, Toyoda H, Landers C, Tyan D, McElree CK, et al. Ulcorative colitis: a genetically heterogeneous disorder defined by genetic (HLA class II) and subclinical (antineutrophil cytoplasmic antibodies) markers. J Clin Invest 1993; 92:1080-1084.
38. Yang H, Vora DK, Targan SR, Toyoda H, Beaudet AL, Rotter JI. Intercellular adhesion molecule 1 gene associations with immunologic subsets of inflammatory bowel disease. Gastroenterology 1995; 109:440-448.
39. Papo M, Quer JC, Pastor RM, Garcia-Pardo G, Prats E, Mirapeix E, et al. Antineutrophil cytoplasmic antibodies in relatives of patients with inflammatory bowel disease. Am J Gastroenterol 1996; 91:1512-1515.
40. Garcia-Paredes J, Bioque G, Crusius JBA, García-González A, López-Nava G, Diaz-Rubio M, et al. The interleukin-1 receptor antagonist gene polymorphism in Spanish IBD patients [Abstract]. Gastroenterology 1996; 110:A914.
41. Tountas NA, Yang H, Coulter DL, Rotter JI, Cominelli F. Increased carriage of allele 2 of IL-1 receptor antagonist (IL-1 ra) in Jewish populations: the strongest known genetic association in ulcerative colitis [Abstract]. Gastroenterology 1996; 110:A1029.
42. Futami S, Aoyama N, Honsako Y, Tamura T, Morimoto S, Nakashima T, et al. HLA-DRB1 1502 allele, subtype of DR15 is associated with susceptibility to ulcerative colitis and its progression. Dig Dis Sci 1995; 40:814-818.
43. Bioque G, Crusius JBA, Koutroubakis I, Bouma G, Kostense PJ, Meuwissen SGM, et al. Allelic polymorphism in IL-1 β and IL-1 receptor antagonist (IL-1Ra) genes in inflammatory bowel disease. Clin Exp Immunol 1995; 102:379-383.
44. Plevy SE, Targan SR, Yang H, Fernandez D, Rotter JI, Toyoda H. Tumor necrosis factor microsatellites define a Crohn's disease-associated haplotype on chromosome 6. Gastroenterology 1996; 110:1053-1060.
45. Bouma G, Xia B, Crusius JBA, Bioque G, Koutroubakis I, Von Blomberg BME, et al. Distribution of four polymorphisms in the tumor necrosis factor (TNF) genes in patients with inflammatory bowel disease (IBD). Clin Exp Immunol 1996; 103:391-396.
46. Heresbach D, Ababou A, Bourienne A, Alizadeh M, Quelvennec E, Pagenault M, et al. Etude du polymorphisme des microsatellites et des gènes du tumor necrosis factor (TNF) au cours des maladies inflammatoires chroniques de l'intestin. Gastroenterol Clin Biol 1997; 21:555-561.
47. Sugimura K, Asakura H, Mizuki N, Inoue M, Hibi T, Yagita A, et al. Analysis of genes within the HLA region affecting susceptibility to ulcerative colitis. Hum Immunol 1993; 36:112-118.
48. Satsangi J, Landers C, Welsh K, Koss K, Targan S, Jewell DP. ANCA and HLA genes in North European patients with ulcerative colitis [Abstract]. Gastroenterology 1996; 110:A1009.
49. Cambridge G, Rampton DS, Stevens TRJ, McCarthy DA, Kamm M, Leaker B. Anti-neutrophil antibodies in inflammatory bowel disease: prevalence and diagnostic role. Gut 1992; 33:668-674.
50. Patel RT, Stokes R, Birch D, Ibbotson J, Keighley MRB. Influence of total colectomy on serum antineutrophil cytoplasmic antibodies in inflammatory bowel disease. Br J Surg 1994; 81:724-726.
51. Kossa K, Coulthart A, Ives CT, Pusey CD, Hodgson JF. Antigen specificity of circulating anti-neutrophil cytoplasmic antibodies in inflammatory bowel disease. Eur J Gastroenterol Hepatol 1995; 7:783-789.
52. Castellino F, Rosina F, Bansi DS, Bauducci M, Touscoz GA, Giorda L, et al. Anti-neutrophil cytoplasmic antibodies in inflammatory bowel disease: do they recognize different subsets of a heterogeneous disease? Eur J Gastroenterol Hepatol 1995; 7:859-864.
53. Hertervig E, Wieslander J, Johansson C, Wiik A, Nilsson A. Anti-neutrophil cytoplasmic antibodies in chronic inflammatory bowel disease. Scand J Gastroenterol 1995; 30:693-698.